Ligne de temps
Michael White
Responsable de Structure
06 janv. 2024
publication
PvDBPII elicits multiple antibody-mediated mechanisms that reduce growth in a Plasmodium vivax challenge trial.
Lire plus08 déc. 2023
22 nov. 2023
event
DPT Parasites and Insects Vectors Seminar – Victoria INGHAM “Insecticides and Parasites: Do they interact ?”
Lire plus09 oct. 2023
05 oct. 2023
01 juin 2023
publication
Accelerating towards P. vivax elimination with a novel serological test-and-treat strategy: a modelling case study in Brazil.
Lire plus01 juin 2023
publication
Estimated protection against COVID-19 based on predicted neutralisation titres from multiple antibody measurements in a longitudinal cohort, France, April 2020 to November 2021.
Lire plus01 janv. 2023
01 sept. 2022
publication
Neutralising antibody responses to SARS-CoV-2 omicron among elderly nursing home residents following a booster dose of BNT162b2 vaccine: A community-based, prospective, longitudinal cohort study.
Lire plus02 août 2022
publication
Zika vector competence data reveals risks of outbreaks: the contribution of the European ZIKAlliance project.
Lire plus08 juil. 2022
publication
Kinetics of the SARS-CoV-2 Antibody Avidity Response Following Infection and Vaccination.
Lire plus18 mars 2022
publication
Developing sero-diagnostic tests to facilitate Plasmodium vivax Serological Test-and-Treat approaches: modeling the balance between public health impact and overtreatment.
Lire plus20 déc. 2021
publication
How radical is radical cure? Site-specific biases in clinical trials underestimate the effect of radical cure on Plasmodium vivax hypnozoites.
Lire plus07 déc. 2021
publication
Using observed incidence to calibrate the transmission level of a mathematical model for Plasmodium vivax dynamics including case management and importation.
Lire plus16 nov. 2021
publication
Kinetics of the Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response and Serological Estimation of Time Since Infection.
Lire plus26 juil. 2021
news
Humoral immunity to SARS-CoV-2 and seasonal coronaviruses in children and adults in north-eastern France
Lire plus22 juil. 2021
publication
Humoral immunity to SARS-CoV-2 and seasonal coronaviruses in children and adults in north-eastern France.
Lire plus11 juin 2021
publication
Reduced blood-stage malaria growth and immune correlates in humans following RH5 vaccination.
Lire plus01 juin 2021
publication
IgG Antibody Responses Are Preferential Compared With IgM for Use as Serological Markers for Detecting Recent Exposure to Plasmodium vivax Infection.
Lire plus18 mai 2021
publication
Asymptomatic and symptomatic SARS-CoV-2 infections elicit polyfunctional antibodies.
Lire plus12 avr. 2021
project
Mathematical modelling of the roll-out and potential impact of tafenoquine on Plasmodium vivax in Brazil
Lire plus12 avr. 2021
project
Serological markers of recent exposure as surrogate biomarkers of hypnozoite carriage: a proof-of-concept study
Lire plus12 avr. 2021
12 avr. 2021
project
Algorithms and multiplex assays for integrated serological surveillance of malaria and neglected tropical diseases
Lire plus06 avr. 2021
01 avr. 2021
publication
Estimated impact of tafenoquine for Plasmodium vivax control and elimination in Brazil: A modelling study.
Lire plus08 mars 2021
publication
Development and validation of an in silico decision-tool to guide optimisation of intravenous artesunate dosing regimens for severe falciparum malaria patients.
Lire plus02 mars 2021
publication
Fine-scale spatio-temporal mapping of asymptomatic and clinical P. falciparum infections: epidemiological evidence for targeted malaria elimination interventions.
Lire plus02 mars 2021
publication
PvMSP8 as a Novel Plasmodium vivax Malaria Sero-Marker for the Peruvian Amazon.
Lire plus01 mars 2021
publication
Novel anti-malarial drug strategies to prevent artemisinin partner drug resistance: A model-based analysis.
Lire plus12 févr. 2021
01 févr. 2021
publication
Heterogeneity in response to serological exposure markers of recent Plasmodium vivax infections in contrasting epidemiological contexts.
Lire plus01 févr. 2021
publication
Multiplex assays for the identification of serological signatures of SARS-CoV-2 infection: an antibody-based diagnostic and machine learning study.
Lire plus01 janv. 2021
publication
Application of 23 Novel Serological Markers for Identifying Recent Exposure to Plasmodium vivax Parasites in an Endemic Population of Western Thailand.
Lire plus01 déc. 2020
publication
Antibody Profiles to P. falciparum Antigens Over Time Characterize Acute and Long-Term Malaria Exposure in an Area of Low and Unstable Transmission.
Lire plus19 nov. 2020
publication
Forest malaria in Cambodia: the occupational and spatial clustering of Plasmodium vivax and Plasmodium falciparum infection risk in a cross-sectional survey in Mondulkiri province, Cambodia.
Lire plus01 sept. 2020
publication
The use of serology for trachoma surveillance: Current status and priorities for future investigation.
Lire plus11 mai 2020
publication
Development and validation of serological markers for detecting recent Plasmodium vivax infection.
Lire plus19 mars 2020
publication
Practical example of multiple antibody screening for evaluation of malaria control strategies
Lire plus01 janv. 2020
publication
Global Repertoire of Human Antibodies Against Plasmodium falciparum RIFINs, SURFINs, and STEVORs in a Malaria Exposed Population.
Lire plus24 oct. 2019
19 août 2019
publication
Antibodies to Plasmodium vivax reticulocyte binding protein 2b are associated with protection against P. vivax malaria in populations living in low malaria transmission regions of Brazil and Thailand
Lire plus19 août 2019
publication
Characterising antibody kinetics from multiple influenza infection and vaccination events in ferrets
Lire plus29 avr. 2019
04 avr. 2019
28 mars 2019
publication
Molecular epidemiology of residual Plasmodium vivax transmission in a paediatric cohort in Solomon Islands
Lire plus21 févr. 2019
12 févr. 2019
publication
Priority use cases for antibody-detecting assays of recent malaria exposure as tools to achieve and sustain malaria elimination
Lire plus08 févr. 2019
publication
Antibody kinetics following vaccination with MenAfriVac: an analysis of serological data from randomised trials
Lire plus05 févr. 2019
publication
Targets of complement-fixing antibodies in protective immunity against malaria in children
Lire plus30 janv. 2019
publication
Antibody responses to merozoite antigens after natural Plasmodium falciparum infection: kinetics and longevity in absence of re-exposure.
Lire plus21 déc. 2018
24 sept. 2018
publication
Comprehensive analysis of antibody responses to Plasmodium falciparum erythrocyte membrane protein 1 domains
Lire plus21 août 2018
17 août 2018
publication
Mathematical modelling of the impact of expanding levels of malaria control interventions on Plasmodium vivax
Lire plus17 avr. 2018
publication
Plasmodium vivax and Plasmodium falciparum infection dynamics: re-infections, recrudescences and relapses
Lire plus06 déc. 2017
04 déc. 2017
publication
Sero-catalytic and Antibody Acquisition Models to Estimate Differing Malaria Transmission Intensities in Western Kenya
Lire plus26 sept. 2017
publication
Identification of highly-protective combinations of recombinant proteins for vaccine development
Lire plus23 sept. 2017
publication
Sustained Malaria Control Over an 8-Year Period in Papua New Guinea: The Challenge of Low-Density Asymptomatic Plasmodium Infections
Lire plus11 sept. 2017
publication
Naturally acquired antibody responses to more than 300 Plasmodium vivax proteins in three geographic regions
Lire plus27 juil. 2017
publication
Population-level estimates of the proportion of Plasmodium vivax blood-stage infections attributable to relapses among febrile patients attending Adama Malaria Diagnostic Centre, East Shoa Zone, Oromia, Ethiopia
Lire plus28 avr. 2017
publication
Asymptomatic Plasmodium vivax infections induce robust IgG responses to multiple blood-stage proteins in a low-transmission region of western Thailand
Lire plus12 janv. 2017
publication
Antibody profiles to wheat germ cell-free system synthesized Plasmodium falciparum proteins correlate with protection from symptomatic malaria in Uganda
Lire plus08 janv. 2017
publication
Theoretical Implications of a Pre-Erythrocytic Plasmodium vivax Vaccine for Preventing Relapses
Lire plus17 oct. 2016
06 oct. 2016
16 mai 2016
publication
An Antibody Screen of a Plasmodium vivax Antigen Library Identifies Novel Merozoite Proteins Associated with Clinical Protection
Lire plus28 mars 2016
publication
Different Regions of Plasmodium falciparum Erythrocyte-Binding Antigen 175 Induce Antibody Responses to Infection of Varied Efficacy
Lire plus06 déc. 2015
publication
Current Mathematical Models for Analyzing Anti-Malarial Antibody Data with an Eye to Malaria Elimination and Eradication
Lire plus06 nov. 2015
publication
Public health impact and cost-effectiveness of the RTS,S/AS01 malaria vaccine: a systematic comparison of predictions from four mathematical models
Lire plus27 oct. 2015
publication
Strategies for understanding and reducing the Plasmodium vivax and Plasmodium ovale hypnozoite reservoir in Papua New Guinean children: a randomised placebo-controlled trial and mathematical model
Lire plus23 oct. 2015
publication
Vaccine approaches to malaria control and elimination: Insights from mathematical models
Lire plus02 sept. 2015
publication
Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial
Lire plus23 avr. 2015
publication
Malaria morbidity and mortality in Ebola-affected countries caused by decreased health-care capacity, and the potential effect of mitigation strategies: a modelling analysis
Lire plus05 avr. 2015
publication
Potential effects of warmer worms and vectors on onchocerciasis transmission in West Africa
Lire plus18 nov. 2014
publication
Modelling the contribution of the hypnozoite reservoir to Plasmodium vivax transmission
Lire plus05 nov. 2014
publication
Subclass responses and their half-lives for antibodies against EBA175 and PfRh2 in naturally acquired immunity against Plasmodium falciparum malaria
Lire plus01 août 2014
publication
Surveillance of low pathogenic novel H7N9 avian influenza in commercial poultry barns: detection of outbreaks and estimation of virus introduction time
Lire plus24 juil. 2014
publication
Transmission and control of Plasmodium knowlesi: a mathematical modelling study
Lire plus10 juil. 2014
publication
A combined analysis of immunogenicity, antibody kinetics and vaccine efficacy from phase 2 trials of the RTS,S malaria vaccine
Lire plus01 mai 2014
publication
Negative cross resistance mediated by co-treated bed nets: a potential means of restoring pyrethroid-susceptibility to malaria vectors
Lire plus08 avr. 2014
publication
Dynamics of the antibody response to Plasmodium falciparum infection in African children
Lire plus23 août 2013
publication
Quantifying the mosquito’s sweet tooth: modelling the effectiveness of attractive toxic sugar baits (ATSB) for malaria vector control
Lire plus08 août 2013
08 août 2013
publication
The design and statistical power of treatment re-infection studies of the association between pre-erythrocytic immunity and infection with Plasmodium falciparum
Lire plus07 juin 2013
16 avr. 2013
publication
The relationship between RTS,S vaccine-induced antibodies, CD4⁺ T cell responses and protection against Plasmodium falciparum infection
Lire plus01 mars 2013
publication
Efficacy of RTS,S malaria vaccines: individual-participant pooled analysis of phase 2 data
Lire plus03 nov. 2011
publication
Costs and cost-effectiveness of malaria control interventions–a systematic review
Lire plus28 juil. 2011
publication
Modelling the impact of vector control interventions on Anopheles gambiae population dynamics
Lire plus24 mai 2011
publication
The potential contribution of mass treatment to the control of Plasmodium falciparum malaria
Lire plus13 oct. 2010
10 août 2010
publication
Reducing Plasmodium falciparum malaria transmission in Africa: a model-based evaluation of intervention strategies
Lire plus23 mars 2010
publication
Heterogeneity in malaria exposure and vaccine response: implications for the interpretation of vaccine efficacy trials
Lire plus16 nov. 2009
15 juil. 2008